The global Multi-process Human Resources Outsourcing (MPHRO) market grew at a steady rate in 2019 but experienced short-term disruption due to COVID-19 in 2020. While on the one hand, the pandemic impacted contract renewals and large-scale initiatives, on the other hand, increasing demand for immediate cost takeout / cash unlock and digitalization accelerated new digital initiatives and drove growth in MPHRO.
In 2019, large-scale transformation deals, increasing number of first-time outsourcers (especially in the SMB and mid-market segment), and increasing demand for next-generation technology were factors driving market growth. Considering these, service providers are enhancing their capabilities in these areas to support enterprise clients on their journeys toward a next-generation HR operating model.
This research aims to help providers benchmark their capabilities against their competitors and buyers / potential buyers to evaluate different service providers based on their sourcing needs. We analyze:
Relative positioning of 20 service providers on the Everest Group PEAK Matrix® for MPHRO
MPHRO service provider landscape
Key strengths and limitations for service providers
Scope
MPHRO deals in which a minimum of three HR processes are included
Deals in which the buyer employee size is 3,000 or more
All geographies and industries
Contents
This report examines the dynamics of the MPHRO service provider landscape. It provides a deep-dive analysis into how the service providers shape up in terms of their market impact and vision & capability. Based on the comprehensive Everest Group PEAK Matrix, 20 MPHRO service providers are segmented into Leaders, Major Contenders, and Aspirants. In addition:
This report features a dedicated section that provides an overview of the service provider landscape and the top service providers across geographies, industries, and buyer sizes
This report also contains sourcing considerations (strengths and limitations) enterprises should be aware of for each of the 20 MPHRO service providers' strengths and areas of improvement
Traditionally considered to be a cost-function by lifesciences enterprises, the pharmacovigilance and device-vigilance / complaint management market is finally getting its long-due attention from all industry sections – including regulatory agencies…
